Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Loss of primary cilia increases polycystin-2 and TRPV4 and the appearance of a nonselective cation channel in the mouse cortical collecting duct.

Saigusa T, Yue Q, Bunni MA, Bell PD, Eaton DC.

Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F632-F637. doi: 10.1152/ajprenal.00210.2019. Epub 2019 Jul 17.

PMID:
31313950
2.

Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.

Fitzgibbon WR, Dang Y, Bunni MA, Baicu CF, Zile MR, Mullick AE, Saigusa T.

Am J Physiol Renal Physiol. 2018 Feb 1;314(2):F210-F218. doi: 10.1152/ajprenal.00389.2017. Epub 2017 Oct 11.

3.

Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease.

Saigusa T, Dang Y, Bunni MA, Amria MY, Steele SL, Fitzgibbon WR, Bell PD.

Physiol Rep. 2015 May;3(5). pii: e12405. doi: 10.14814/phy2.12405.

4.

Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage.

Sas KM, Yin H, Fitzgibbon WR, Baicu CF, Zile MR, Steele SL, Amria M, Saigusa T, Funk J, Bunni MA, Siegal GP, Siroky BJ, Bissler JJ, Bell PD.

Am J Physiol Renal Physiol. 2015 Jul 1;309(1):F79-87. doi: 10.1152/ajprenal.00652.2014. Epub 2015 Apr 22.

5.

Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study.

Baccillieri MS, Gasparini G, Benacchio L, Zorzi A, Marras E, Zerbo F, Tomasi L, Vaccari D, Pastore G, Bonanno C, Molon G, Zanotto G, Fusco A, Carasi M, Zorzi A, Calzolari V, Ignatiuk B, Cannas S, Vaglio A, Al Bunni M, Pedrini A, Olivieri A, Rampazzo R, Minicuci N, Corrado D, Verlato R.

J Interv Card Electrophysiol. 2015 Jun;43(1):45-54. doi: 10.1007/s10840-015-9980-9. Epub 2015 Feb 19.

PMID:
25690336
6.

Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy.

Siroky BJ, Yin H, Dixon BP, Reichert RJ, Hellmann AR, Ramkumar T, Tsuchihashi Z, Bunni M, Dillon J, Bell PD, Sampson JR, Bissler JJ.

Am J Physiol Renal Physiol. 2014 Sep 1;307(5):F560-70. doi: 10.1152/ajprenal.00569.2013. Epub 2014 Jun 11.

7.

Deletion of airway cilia results in noninflammatory bronchiectasis and hyperreactive airways.

Gilley SK, Stenbit AE, Pasek RC, Sas KM, Steele SL, Amria M, Bunni MA, Estell KP, Schwiebert LM, Flume P, Gooz M, Haycraft CJ, Yoder BK, Miller C, Pavlik JA, Turner GA, Sisson JH, Bell PD.

Am J Physiol Lung Cell Mol Physiol. 2014 Jan;306(2):L162-9. doi: 10.1152/ajplung.00095.2013. Epub 2013 Nov 8.

8.

Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism.

Richard EM, Thiyagarajan T, Bunni MA, Basher F, Roddy PO, Siskind LJ, Nietert PJ, Nowling TK.

PLoS One. 2013 Sep 10;8(9):e75175. doi: 10.1371/journal.pone.0075175. eCollection 2013.

9.

The bradykinin B(2) receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines.

Kramarenko II, Morinelli TA, Bunni MA, Raymond JR Sr, Garnovskaya MN.

Cancer Manag Res. 2012;4:195-205. doi: 10.2147/CMAR.S31847. Epub 2012 Jul 26.

10.

Role of integrins in angiotensin II-induced proliferation of vascular smooth muscle cells.

Bunni MA, Kramarenko II, Walker L, Raymond JR, Garnovskaya MN.

Am J Physiol Cell Physiol. 2011 Mar;300(3):C647-56. doi: 10.1152/ajpcell.00179.2010. Epub 2010 Dec 9.

11.

Bradykinin B2 receptor interacts with integrin alpha5beta1 to transactivate epidermal growth factor receptor in kidney cells.

Kramarenko II, Bunni MA, Raymond JR, Garnovskaya MN.

Mol Pharmacol. 2010 Jul;78(1):126-34. doi: 10.1124/mol.110.064840. Epub 2010 Apr 12.

12.

Identification of functional bradykinin B(2) receptors endogenously expressed in HEK293 cells.

Kramarenko II, Bunni MA, Morinelli TA, Raymond JR, Garnovskaya MN.

Biochem Pharmacol. 2009 Jan 15;77(2):269-76. doi: 10.1016/j.bcp.2008.09.027. Epub 2008 Oct 1.

13.

The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis.

Hooijberg JH, Peters GJ, Assaraf YG, Kathmann I, Priest DG, Bunni MA, Veerman AJ, Scheffer GL, Kaspers GJ, Jansen G.

Biochem Pharmacol. 2003 Mar 1;65(5):765-71.

PMID:
12628490
14.
16.

Response to 5-fluorouracil chemotherapy is modified by dietary folic acid deficiency in Apc(Min/+) mice.

Tucker JM, Davis C, Kitchens ME, Bunni MA, Priest DG, Spencer HT, Berger FG.

Cancer Lett. 2002 Dec 10;187(1-2):153-62. Erratum in: Cancer Lett. 2003 Dec 8;202(1):119.

PMID:
12359363
17.

Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.

Mauritz R, Peters GJ, Priest DG, Assaraf YG, Drori S, Kathmann I, Noordhuis P, Bunni MA, Rosowsky A, Schornagel JH, Pinedo HM, Jansen G.

Biochem Pharmacol. 2002 Jan 15;63(2):105-15.

PMID:
11841783
18.

Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.

van der Wilt CL, Backus HH, Smid K, Comijn L, Veerman G, Wouters D, Voorn DA, Priest DG, Bunni MA, Mitchell F, Jackman AL, Jansen G, Peters GJ.

Cancer Res. 2001 May 1;61(9):3675-81.

19.

Accumulation of plasma reduced folates after folic acid administration.

Priest DG, Schmitz JC, Bunni MA.

Semin Oncol. 1999 Apr;26(2 Suppl 6):38-41.

PMID:
10598553
20.
21.

A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.

Jansen G, Mauritz R, Drori S, Sprecher H, Kathmann I, Bunni M, Priest DG, Noordhuis P, Schornagel JH, Pinedo HM, Peters GJ, Assaraf YG.

J Biol Chem. 1998 Nov 13;273(46):30189-98.

22.

Effects of antisense-based folypoly-gamma-glutamate synthetase down-regulation on reduced folates and cellular proliferation in CCRF-CEM cells.

Liu Y, Raghunathan K, Hill C, He Y, Bunni MA, Barredo J, Priest DG.

Biochem Pharmacol. 1998 Jun 15;55(12):2031-7.

PMID:
9714324
23.

Tolerance to the repolarization effects of rac-sotalol during long-term treatment.

Padrini R, Gusella M, Al Bunni M, Piovan D, Zordan R, Magnolfi G, Maiolino P, Ferrari M.

Br J Clin Pharmacol. 1997 Nov;44(5):463-70.

24.

Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.

Jansen G, Mauritz RM, Assaraf YG, Sprecher H, Drori S, Kathmann I, Westerhof GR, Priest DG, Bunni M, Pinedo HM, Schornagel JH, Peters GJ.

Adv Enzyme Regul. 1997;37:59-76.

PMID:
9381986
25.

Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo.

Miotti S, Facheris P, Tomassetti A, Bottero F, Bottini C, Ottone F, Colnaghi MI, Bunni MA, Priest DG, Canevari S.

Int J Cancer. 1995 Nov 3;63(3):395-401.

PMID:
7591238
26.

Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.

Pizzorno G, Moroson BA, Cashmore AR, Russello O, Mayer JR, Galivan J, Bunni MA, Priest DG, Beardsley GP.

Cancer Res. 1995 Feb 1;55(3):566-73.

27.
28.

Altered transport of folic acid and antifolates through the carrier mediated reduced folate transport system in a human leukemia cell line resistant to (6R) 5,10-dideazatetrahydrofolic acid (DDATHF).

Pavlovic M, Leffert JJ, Russello O, Bunni MA, Beardsley GP, Priest DG, Pizzorno G.

Adv Exp Med Biol. 1993;338:775-8. No abstract available.

PMID:
8304227
29.

Folate metabolites as modulators of antitumor drug activity.

Priest DG, Schmitz JC, Bunni MA.

Adv Exp Med Biol. 1993;338:693-8. Review. No abstract available.

PMID:
8304208
30.

Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously.

Priest DG, Schmitz JC, Bunni MA, Stuart RK.

J Natl Cancer Inst. 1991 Dec 18;83(24):1806-12.

PMID:
1744924
31.

A sensitive radioenzymatic assay for (S)-5-formyltetrahydrofolate.

Priest DG, Bunni MA, Romero-Fredes LR, Schmitz JC, Whiteley JM.

Anal Biochem. 1991 Aug 1;196(2):284-9.

PMID:
1776677
32.

Human red blood cell-mediated metabolism of leucovorin [(R,S)5-formyltetrahydrofolate].

Bunni MA, Priest DG.

Arch Biochem Biophys. 1991 May 1;286(2):633-7.

PMID:
1897982
33.

Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin.

Romanini A, Lin JT, Niedzwiecki D, Bunni M, Priest DG, Bertino JR.

Cancer Res. 1991 Feb 1;51(3):789-93.

34.

The effect of methotrexate on the folate coenzyme pools in human hepatoma cells in culture.

Galivan J, Rhee M, Priest DG, Bunni M, Freisheim JH, Whiteley JM.

Adv Exp Med Biol. 1991;309A:75-8. No abstract available.

PMID:
1665010
35.

Role of substrate depletion in the inhibition of thymidylate biosynthesis by the dihydrofolate reductase inhibitor trimetrexate in cultured hepatoma cells.

Rhee MS, Balinska M, Bunni M, Priest DG, Maley GF, Maley F, Galivan J.

Cancer Res. 1990 Jul 1;50(13):3979-84.

36.

Thallium in biochemistry.

Douglas KT, Bunni MA, Baindur SR.

Int J Biochem. 1990;22(5):429-38. Review. No abstract available.

PMID:
2189755
37.
39.

Accumulation of tetrahydrofolates in human plasma after leucovorin administration.

Bunni MA, Rembiesa BM, Priest DG, Sahovic E, Stuart R.

Cancer Chemother Pharmacol. 1989;23(6):353-7.

PMID:
2785439
40.

The enhancement of the activity of 10-propargyl-5,8-dideazafolate and 5,10-dideazatetrahydrofolate by inhibitors of dihydrofolate reductase.

Galivan J, Rhee MS, Johnson TB, Chou TC, Nair MG, Bunni M, Priest D.

Adv Enzyme Regul. 1989;28:13-21.

PMID:
2624172
41.
42.

[Myocardial infarct before 45 years of age: significance of the coronarographic study in asymptomatic patients].

Di Mario C, Zanchetta M, Carlon R, Al Bunni M, Allegri P, Maiolino P.

G Ital Cardiol. 1987 Nov;17(11):922-9. Italian.

PMID:
3446566
43.

Organothallium(III) reagents for modification of biomacromolecules: irreversible labelling of phosphoglycerate kinase from rabbit muscle.

Bunni MA, Baindur SR, Douglas KT, Drake AF.

Biochim Biophys Acta. 1987 Mar 19;923(3):421-30.

PMID:
3828383
45.

Photoaffinity labelling by S-(p-azidophenacyl)-glutathione of glyoxalase II and glutathione S-transferase.

Seddon AP, Bunni M, Douglas KT.

Biochem Biophys Res Commun. 1980 Jul 16;95(1):446-52. No abstract available.

PMID:
7417267

Supplemental Content

Support Center